Incontinence News and Research

Latest Incontinence News and Research

U.S. market for urological devices to reach over $5.4 billion in 2016

According to a new global report series by iData Research, the leading authority in medical device, dental and pharmaceutical market research, the U.S. market for urological devices is estimated to more than double in value by 2016, reaching over $5.4 billion.

6 Jan 2010

Despite economic downturn, Russia still represents a promising healthcare market

Despite uncertain economic environment, Russia still represents a promising healthcare market with strong potential for further growth.

5 Jan 2010

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

Cryo-Cell International, Inc. a global leader in stem cell innovation, resolves to help women inspire and empower each other to take charge of their health in the New Year, and to spark conversations about the promise of stem cells.

31 Dec 2009

AUA experts urge to focus on urologic health conditions in upcoming year

This new year, make a resolution to improve your health and talk to your doctor about urologic conditions. Although urologic problems may seem embarrassing to talk about, these conditions are more common than you think and a delay in seeking medical attention could cause you unnecessary stress, prolong the problem and even increase your risk for a more serious condition.

30 Dec 2009

LUHS urogynecologists awarded $1M NIH Challenge Grant

The National Institutes of Health (NIH) has awarded a Challenge Grant for $1 million to Loyola University Health System (LUHS) urogynecologists Kimberly Kenton, MD, and Elizabeth Mueller, MD. This places them among the top 2 percent of researchers in the nation to receive this grant.

24 Dec 2009

SCA to invest in incontinence care products

A new production line for incontinence care products will be built in Russia by SCA (STO:SCAA)(STO:SCAB) following the company's assessment that the market for incontinence care products is expected to grow considerably in the years immediately ahead.

18 Dec 2009

LABORIE and meridianEMR integrate their EMR and Urodynamic system for Urologists

As the U.S. ramps up the implementation of EMRs in medical practices in order to lower costs, prevent errors, and improve patient care, meridianEMR and LABORIE MEDICAL have provided a great benefit to Urologists using LABORIE urodynamic systems.

14 Dec 2009

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

LinkMed’s portfolio company Likvor has received an order for Likvor CELDA™ from Uppsala University Hospital (Akademiska Universitetssjukhuset).

11 Dec 2009

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today highlighted the 12-month results of the OrBIT Trial of its Urgent® PC Neuromodulation System that will be published in the January 2010 print edition of THE JOURNAL OF UROLOGY®.

10 Dec 2009

Urodynamix Technologies reviews strategic alternatives for sale of company's assets

Urodynamix Technologies Ltd. today announces that its Board of Directors has initiated a process to review strategic alternatives including the sale of part of or all of the Company's assets.

10 Dec 2009

SOLESTA pivotal study meets primary endpoints for fecal incontinence treatment

Q-Med AB and Oceana Therapeutics, Inc. today announced that the SOLESTA pivotal study succeeded in meeting both primary endpoints for the treatment of fecal incontinence.

8 Dec 2009

Lab grown muscle cells raise hope for gastric reflux and fecal incontinence

A new study shows that muscle cells grown in the lab can restore an intestine's ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat patients with conditions such as gastric reflux and fecal incontinence.

5 Dec 2009

Third-quarter fiscal 2009 results announced by Urodynamix Technologies

Urodynamix Technologies Ltd. today reported its financial results for its fiscal third quarter ended September 30, 2009. The Company reported a loss of $638,287 or $0.01 per share basic and diluted compared to a loss of $737,341or $0.01, basic and diluted, for the comparative quarter of the prior year. Revenue for the quarter ended September 30, 2009 at $15,285, decreased 55% over the same quarter of the prior year.

1 Dec 2009

Second-quarter fiscal 2010 results announced by Medtronic

Medtronic, Inc. today announced financial results for its second quarter of fiscal year 2010, which ended Oct. 30, 2009.

24 Nov 2009

Urodynamix Technologies announces the publication of AMA's 2010 Current Procedural Terminology

Urodynamix Technologies Ltd. today announced that the American Medical Association (AMA) has published its 2010 Current Procedural Terminology (CPT) codes with additions, changes and deletions of billing codes for all medical specialities including urology.

23 Nov 2009

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

Laparoscopic surgeons received their first glimpse of Cook Medical’s uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).

23 Nov 2009

Most Canadians hope OAB symptoms will go away

A recent poll conducted by Leger Marketing, on behalf of the Powder Room - a national education program for those with overactive bladder (OAB) - asked 1,500 Canadians about their bladder health. The findings revealed that although people are experiencing OAB symptoms, most are choosing not to seek medical attention - perhaps assuming the frustrating and embarrassing symptoms will go away, or that they will just have to live with them.

23 Nov 2009

Data from second positive pivotal study of PSD502 for treatment of PE presented

At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora")., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

20 Nov 2009

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

At the annual meeting of the Sexual Medicine Society of North America, Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company, and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC, today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE).

19 Nov 2009

Medspira to manufacture and market Mayo Clinic developed products and technologies

Medspira, and Mayo Clinic have entered into an agreement to commercialize, manufacture and market several Mayo Clinic developed products and technologies invented by Mayo physicians and scientists.

19 Nov 2009

Incontinence News and Research

Latest Incontinence News and Research

U.S. market for urological devices to reach over $5.4 billion in 2016

Despite economic downturn, Russia still represents a promising healthcare market

Cryo-Cell International continues to expand R&D initiatives to accelerate therapeutic benefits of stem cells

AUA experts urge to focus on urologic health conditions in upcoming year

LUHS urogynecologists awarded $1M NIH Challenge Grant

SCA to invest in incontinence care products

LABORIE and meridianEMR integrate their EMR and Urodynamic system for Urologists

Uppsala University Hospital orders CELDA from Likvor for diagnosing NPH

Uroplasty to publish 12-month results of its OrBIT Urgent PC Neuromodulation System trial

Urodynamix Technologies reviews strategic alternatives for sale of company's assets

SOLESTA pivotal study meets primary endpoints for fecal incontinence treatment

Lab grown muscle cells raise hope for gastric reflux and fecal incontinence

Third-quarter fiscal 2009 results announced by Urodynamix Technologies

Second-quarter fiscal 2010 results announced by Medtronic

Urodynamix Technologies announces the publication of AMA's 2010 Current Procedural Terminology

Cook Medical unveils its uterine manipulator/injectors at 38th Global Congress of Minimally Invasive Gynecology

Most Canadians hope OAB symptoms will go away

Data from second positive pivotal study of PSD502 for treatment of PE presented

Positive results from Sciele Pharma's second pivotal study of PSD502 for the treatment of PE

Medspira to manufacture and market Mayo Clinic developed products and technologies

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Incontinence News and Research

Latest Incontinence News and Research

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Newsletters you may be interested in